Marinus Pharmaceuticals Inc (MRNS)
1.33
+0.03
(+2.31%)
USD |
NASDAQ |
May 17, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Free Cash Flow: -113.98M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -113.98M |
December 31, 2023 | -118.12M |
September 30, 2023 | -113.10M |
June 30, 2023 | -118.75M |
March 31, 2023 | -128.40M |
December 31, 2022 | -114.66M |
September 30, 2022 | -115.12M |
June 30, 2022 | -79.69M |
March 31, 2022 | -69.50M |
December 31, 2021 | -58.37M |
September 30, 2021 | -52.29M |
June 30, 2021 | -71.29M |
March 31, 2021 | -63.48M |
December 31, 2020 | -60.91M |
September 30, 2020 | -60.79M |
June 30, 2020 | -58.34M |
March 31, 2020 | -51.26M |
December 31, 2019 | -49.02M |
September 30, 2019 | -41.98M |
June 30, 2019 | -36.77M |
March 31, 2019 | -33.56M |
Date | Value |
---|---|
December 31, 2018 | -27.92M |
September 30, 2018 | -23.43M |
June 30, 2018 | -19.80M |
March 31, 2018 | -18.45M |
December 31, 2017 | -19.27M |
September 30, 2017 | -20.58M |
June 30, 2017 | -24.10M |
March 31, 2017 | -26.25M |
December 31, 2016 | -25.41M |
September 30, 2016 | -24.41M |
June 30, 2016 | -23.62M |
March 31, 2016 | -22.66M |
December 31, 2015 | -20.48M |
September 30, 2015 | -17.40M |
June 30, 2015 | -14.60M |
March 31, 2015 | -11.42M |
December 31, 2014 | -8.589M |
September 30, 2014 | -9.750M |
June 30, 2014 | -7.847M |
March 31, 2014 | -7.067M |
December 31, 2013 | -6.645M |
Free Cash Flow Range, Past 5 Years
-128.40M
Minimum
Mar 2023
-36.77M
Maximum
Jun 2019
-78.79M
Average
-66.49M
Median
Free Cash Flow Benchmarks
Pfizer Inc | 5.106B |
ACADIA Pharmaceuticals Inc | 63.71M |
Alnylam Pharmaceuticals Inc | 127.82M |
Regeneron Pharmaceuticals Inc | 3.930B |
Actinium Pharmaceuticals Inc | -39.72M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -37.46M |
Cash from Investing (Quarterly) | 20.88M |
Cash from Financing (Quarterly) | 0.257M |
Free Cash Flow Per Share (Quarterly) | -0.6589 |
Free Cash Flow to Equity (Quarterly) | -37.96M |
Free Cash Flow Yield | -155.8% |